Actas Dermo-Sifiliográficas

ISSN: 0001-7310

The Official publication of the Spanish Academy of Dermatology and Venereology (AEDV). Actas Dermo-Sifiliográficas, founded in 1909, is the oldest monthly medical journals published in Spain. In the year 2006 has been indexed in the Medlinedatabase, and has become a vehicle for expressing the most current Spanish medicine and modern. All articles are subjected to a rigorous process of revision in pairs, and careful editing for literary and scientific style. Together with the classic Original and Clinical Case Study sections, we also include Reviews, Case Diagnoses, and Book Reviews. Dermo-Sifiliográficas is an essential publication for anyone who needs to be current on all aspects of Spanish and world dermatology.

Actas Dermo-Sifiliográficas ha recibido Factor de Impacto (JCR) por primera vez en 2023.
Guía para autores - Envío de manuscritos

Actas Dermo-Sifiliográficas has received its first journal Impact Factor (JCR) in 2023.
Instructions for authors - Submit an article

Indexed in:

Web of Science, Emerging Sources Citation Index (WoS, Clarivate), PubMed/Medlinee, IME, Embase/Excerpta Medica, Embase, Toxline, Cab Abstracts, Cab Health, Cancerlit NIm, Serline: Biomed, Bibliomed, Pascal, Scopus , IBECS

Graphical abstract
Abstract
Keywords
Resumen
Palabras clave
Introduction
Cutaneous adverse events of braf inhibitors
Keratinocytic malignant and pre-malignant lesions
Benign keratotic lesions
Melanocytic lesions
Pruritus
Hair follicle changes
Photosensitivity
Panniculitis
Maculopapular drug reactions
Serious adverse events
Cutaneous adverse events of mek inhibitors (meki)
Acneiform eruptions
Others
Cutaneous adverse events of combined braf inhibitors and mek inhibitors
Folliculitis
Other
Serious adverse events
Cutaneous adverse events of anti-ctla4 antibodies
Maculopapular exanthema
Pruritus
Vitiligo
Others
Serious adverse events
Cutaneous adverse events of anti-pd1 antibodies
Lichenoid reaction
Vitiligo
Pruritus
Vesiculo-bullous reactions
Others
Serious adverse events
Cutaneous adverse events of combined ctla4 and pd1 blockade
Conclusion
Ethical disclosures
Protection of human and animal subjects
Confidentiality of data
Right to privacy and informed consent
Conflict of interest
Bibliography

Vol. 108. Issue 1.

Pages 6-16 (January - February 2017)

Review

DOI: 10.1016/j.ad.2016.05.019

Full text access

Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management

Efectos cutáneos adversos de los nuevos tratamientos para melanoma: Clasificación y Tratamiento

Download PDF

S.J.E. Hwanga,b,

Corresponding author

shelley.hwang@hotmail.com

Corresponding author.

, R. Anfortha,b, G. Carlosa,b, P. Fernandez-Peñasa,b

a Department of Dermatology, Westmead Hospital, Westmead, NSW, Australia

b Sydney Medical School, The University of Sydney, Sydney, NSW, Australia

Back to article

Statistics

Follow this link to access the full text of the article

Review

Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management

Efectos cutáneos adversos de los nuevos tratamientos para melanoma: Clasificación y Tratamiento

S.J.E. Hwanga,b,

Corresponding author

shelley.hwang@hotmail.com

Corresponding author.

, R. Anfortha,b, G. Carlosa,b, P. Fernandez-Peñasa,b

a Department of Dermatology, Westmead Hospital, Westmead, NSW, Australia

b Sydney Medical School, The University of Sydney, Sydney, NSW, Australia

Read

7849

Times
was read the article

2872

Total PDF

4977

Total HTML

Share statistics

Article information

ISSN: 00017310
Original language: English

DOI:10.1016/j.ad.2016.05.019

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 April	61	22	83
2024 March	72	43	115
2024 February	63	45	108
2024 January	89	50	139
2023 December	62	17	79
2023 November	102	40	142
2023 October	91	64	155
2023 September	69	36	105
2023 August	54	25	79
2023 July	85	46	131
2023 June	82	25	107
2023 May	60	24	84
2023 April	53	30	83
2023 March	79	27	106
2023 February	105	28	133
2023 January	58	23	81
2022 December	94	33	127
2022 November	63	42	105
2022 October	82	34	116
2022 September	63	43	106
2022 August	81	52	133
2022 July	55	45	100
2022 June	87	36	123
2022 May	79	63	142
2022 April	54	39	93
2022 March	75	78	153
2022 February	104	48	152
2022 January	92	62	154
2021 December	76	56	132
2021 November	88	69	157
2021 October	113	82	195
2021 September	50	56	106
2021 August	83	49	132
2021 July	61	54	115
2021 June	84	40	124
2021 May	81	71	152
2021 April	170	133	303
2021 March	109	62	171
2021 February	120	47	167
2021 January	102	27	129
2020 December	62	23	85
2020 November	52	34	86
2020 October	71	31	102
2020 September	64	36	100
2020 August	48	31	79
2020 July	60	41	101
2020 June	69	48	117
2020 May	54	34	88
2020 April	57	31	88
2020 March	63	15	78
2020 February	11	8	19
2020 January	4	0	4
2019 December	26	2	28
2019 November	46	17	63
2019 September	5	2	7
2019 August	4	0	4
2019 July	6	2	8
2019 June	11	2	13
2019 May	6	4	10
2019 April	16	7	23
2019 March	27	4	31
2019 February	11	8	19
2019 January	23	12	35
2018 December	78	2	80
2018 November	7	6	13
2018 October	19	9	28
2018 September	4	1	5
2018 August	1	4	5
2018 July	4	1	5
2018 June	1	1	2
2018 May	1	3	4
2018 April	2	4	6
2018 March	3	1	4
2018 February	44	6	50
2018 January	94	17	111
2017 December	68	15	83
2017 November	67	14	81
2017 October	51	9	60
2017 September	46	20	66
2017 August	49	20	69
2017 July	44	32	76
2017 June	49	23	72
2017 May	51	32	83
2017 April	85	28	113
2017 March	37	38	75
2017 February	47	78	125
2017 January	71	111	182
2016 December	7	39	46
2016 November	0	37	37
2016 October	0	58	58
2016 September	0	5	5

Show all

Follow this link to access the full text of the article

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter